葛兰素史克（GSK）首席执行官米尔思：GLP - 1领域“将变得非常拥挤”。

Group 1 - The core viewpoint is that the GLP-1 sector is expected to become highly competitive, as stated by GSK's CEO, Emma Walmsley [1] Group 2 - GSK is actively monitoring the developments in the GLP-1 market, indicating a strategic focus on this area [1] - The company acknowledges the increasing number of players entering the GLP-1 space, which may impact market dynamics [1] - GSK's leadership is preparing for a more crowded landscape in the GLP-1 sector, suggesting potential shifts in competitive strategies [1]